Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Synergy Pharma (SGYP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 582,646
  • Shares Outstanding, K 224,960
  • Annual Sales, $ 0 K
  • Annual Income, $ -198,610 K
  • 36-Month Beta 1,058.95
  • Price/Sales 218.05
  • Price/Cash Flow N/A
  • Price/Book 13.71

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.57 +0.78%
on 09/15/17
3.25 -20.31%
on 09/05/17
-0.42 (-13.95%)
since 08/22/17
3-Month
2.57 +0.78%
on 09/15/17
4.84 -46.49%
on 06/26/17
-2.00 (-43.57%)
since 06/22/17
52-Week
2.57 +0.78%
on 09/15/17
7.15 -63.78%
on 01/31/17
-2.99 (-53.58%)
since 09/22/16

Most Recent Stories

More News
CORRECTING and REPLACING Synergy Pharmaceuticals to Present at Upcoming September Investor Conferences

In the release dated September 6, 2017, the presentation date and time for the Cantor Fitzgerald Global Healthcare Conference should be changed to Wednesday, September 27, 2017 at 9:45 a.m....

SGYP : 2.59 (-1.89%)
Global Constipation Market Report: Industry Analysis & Outlook 2017-2021 - Research and Markets

The "Global Constipation Market: Industry Analysis & Outlook (2017-2021)" report has been added to Research and Markets' offering.

IRWD : 15.84 (+2.06%)
SCMP : 11.80 (-0.42%)
SGYP : 2.59 (-1.89%)
Biotech Sector Looking to Outperform in 2017

Biotech is a thriving industry, driven by constant innovation and a search for daring new solutions to serious health problems. After several years of struggle, with smaller companies losing out to rising...

XON : 18.75 (unch)
MDT : 79.70 (+0.21%)
AMGN : 185.76 (-0.47%)
SGYP : 2.59 (-1.89%)
EPZM : 16.95 (-9.36%)
Synergy Pharmaceuticals to Present at Upcoming September Investor Conferences

Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) today announced that the company will present corporate updates at three upcoming investor conferences in New York City during September:

SGYP : 2.59 (-1.89%)
2017 is a Transformative Year for Synergy, Q2 Review, and Analyst Outlook

NEW YORK, NY / ACCESSWIRE / September 6, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive...

SGYP : 2.59 (-1.89%)
Synergy Pharmaceuticals Secures $300 Million Debt Financing

Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), announced today that the Company has closed on a $300 million debt financing structured as senior secured loans from CRG LP, a healthcare focused...

SGYP : 2.59 (-1.89%)
Constipation Treatment Market to Reach US$22.93 Billion by 2025: Escalating Geriatric Population Driving Demand, Says TMR

A freshly-compiled intelligence study by Transparency Market Research (TMR) has noted that a vast number of players are participating in the global constipation treatment market, which has been a prevalent...

VRX.TO : 17.30 (-1.42%)
BAYRY : 33.0300 (-0.09%)
IRWD : 15.84 (+2.06%)
SCMP : 11.80 (-0.42%)
PBH : 49.11 (-0.43%)
SGYP : 2.59 (-1.89%)
SGIOF : 52.2000 (-0.57%)
Breakfast Technical Briefing on Drug Makers Stocks -- Depomed, Synergy Pharma, Novo Nordisk, and SciClone Pharma

If you want a Stock Review on DEPO, SGYP, NVO, or SCLN then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. DailyStockTracker.com has issued research...

SCLN : 11.10 (-0.45%)
NVO : 49.22 (+0.33%)
SGYP : 2.59 (-1.89%)
DEPO : 5.90 (-0.34%)
SmarTrend Watching for Potential Rebound in Shares of Synergy Pharmace After 3.09% Loss

Synergy Pharmace (NASDAQ:SGYP) traded in a range yesterday that spanned from a low of $2.88 to a high of $3.25. Yesterday, the shares fell 3.1%, which took the trading range below the 3-day low of $2.91...

SGYP : 2.59 (-1.89%)
Synergy Pharmaceuticals Reports Second Quarter 2017 Financial Results and Business Update

--Total TRULANCE monthly prescription volume has increased on average more than 182% month-over-month since launch in March 2017

SGYP : 2.59 (-1.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More

Business Summary

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. Its lead drug candidate plecanatide is a guanylyl cyclase C receptor agonist, to treat GI disorders, primarily chronic constipation and constipation-predominant-...

See More

Support & Resistance

2nd Resistance Point 2.68
1st Resistance Point 2.63
Last Price 2.59
1st Support Level 2.56
2nd Support Level 2.54

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.